Ischemic stroke risk in East Asian patients with CHA₂DS₂-VASc score of 1: systematic review and meta-analysis

References

• Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012; 142(6): 1489–1498. Epub 2012/03/31. 10.1378/chest.11-2888 PubMed PMID: 22459778.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272. 10.1378/chest.09-1584 PubMed PMID: 19762550.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016. PubMed PMID: 27567408. DOI:10.1093/eurheartj/ehw210
   Web of Science ®Google Scholar
• National-Institute-for-Health-and-Care-Excellence. Atrial fibrillation: the management of atrial fibrillation. (Clinical guideline 180.) 2014. http://guidance.nice.org.uk/CG180.
   Google Scholar
• January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64(21):e1–76. 10.1016/j.jacc.2014.03.022 PubMed PMID: 24685669
   PubMed Web of Science ®Google Scholar
• Joundi RA, Cipriano LE, Sposato LA, et al., Stroke Outcomes Research Working G. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc score of 1: systematic review and meta-analysis. Stroke. 2016; 47(5): 1364–1367. 10.1161/STROKEAHA.115.012609 PubMed PMID: 27026630.
   PubMed Web of Science ®Google Scholar
• Chiang CE, Wang KL, Lip GY. Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost. 2014;111(5):789–797. 10.1160/TH13-11-0948 PubMed PMID: 24500243.
   PubMed Web of Science ®Google Scholar
• Lip GY, Wang KL, Chiang CE. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal. Int J Cardiol. 2015;180:246–254. DOI:10.1016/j.ijcard.2014.11.182 PubMed PMID: 25463377.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341. 10.1016/j.ijsu.2010.02.007 PubMed PMID: 20171303.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;28315:2008–2012. PubMed PMID: 10789670.
   Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. 10.1136/bmj.327.7414.557 PubMed PMID: 12958120; PubMed Central PMCID: PMCPMC192859.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M, Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;504:1088–1101. PubMed PMID: 7786990.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ling L, Su G, et al. Effect of intermittent versus chronic calorie restriction on tumor incidence: a systematic review and meta-analysis of animal studies. Sci Rep. 2016;6:33739. DOI:10.1038/srep33739 PubMed PMID: 27653140; PubMed Central PMCID: PMCPMC5031958.
   PubMed Web of Science ®Google Scholar
• Guo Y, Apostolakis S, Blann AD, et al. Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation. Int J Cardiol. 2013; 168(2): 904–909. Epub 2012/11/22. 10.1016/j.ijcard.2012.10.052 PubMed PMID: 23167998.
   PubMed Web of Science ®Google Scholar
• Chao TF, Liu CJ, Wang KL, et al. Using the CHA2DS2-VASc score for refining stroke risk stratification in ‘low-risk’ Asian patients with atrial fibrillation. J Am Coll Cardiol. 2014; 64(16): 1658–1665. 10.1016/j.jacc.2014.06 1203PubMed PMID: 25323252.
   PubMed Web of Science ®Google Scholar
• Chao TF, Liu CJ, Wang KL, et al. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?. J Am Coll Cardiol. 2015; 65(7): 635–642. 10.1016/j.jacc.2014.11.046 PubMed PMID: 25677422.
   PubMed Web of Science ®Google Scholar
• Hung Y, Chao TF, Liu CJ, et al. Is an oral anticoagulant necessary for young atrial fibrillation patients with a CHA2DS2-vasc score of 1 (men) or 2 (women)?. J Am Heart Assoc. 2016; 5(10). Epub 2016/10/06. 10.1161/JAHA.116.003839 PubMed PMID: 27702803.
   Web of Science ®Google Scholar
• Chan PH, Lau CP, Tse HF, et al. CHA2DS2-vasc recalibration with an additional age category (50-64 years) enhances stroke risk stratification in Chinese patients with atrial fibrillation. Can J Cardiol. 2016. PubMed PMID: 27523274. DOI:10.1016/j.cjca.2016.05.009
   Web of Science ®Google Scholar
• Huang D, Anguo L, Yue WS, et al. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1. Pacing Clin Electrophysiol. 2014;37(11):1442–1447. 10.1111/pace.12445 PubMed PMID: 25039724.
   PubMed Web of Science ®Google Scholar
• Komatsu T, Tachibana H, Satoh Y, et al. Relationship between CHA(2)DS(2)-VASc scores and ischemic stroke/cardiovascular events in Japanese patients with paroxysmal atrial fibrillation not receiving anticoagulant therapy. J Cardiol. 2012; 59(3): 321–328. 10.1016/j.jjcc.2012.01.003 PubMed PMID: 22386575.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Yamashita T, Okumura K, et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy–pooled analysis of the Shinken Database, J-RHYTHM registry, and Fushimi AF registry. Circ Journal: Official Journal Jpn Circ Soc. 2015; 79(2): 432–438. Epub 2014/12/17. 10.1253/circj.CJ-14-1131 PubMed PMID: 25501800.
   PubMed Web of Science ®Google Scholar
• Toyoda K, Yasaka M, Uchiyama S, et al. CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the bleeding with antithrombotic therapy study. Hypertens Res. 2014; 37(5): 463–466. 10.1038/hr.2013.150 PubMed PMID: 24196199.
   PubMed Web of Science ®Google Scholar
• Chao TF, Lip GY, Liu CJ, et al. Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study. Stroke. 2016; 47(10): 2462–2469. 10.1161/STROKEAHA.116.013880 PubMed PMID: 27625386.
   PubMed Web of Science ®Google Scholar
• Tomita H, Okumura K, Inoue H, et al. Validation of risk scoring system excluding female sex from CHA2DS2-VASc in Japanese patients with nonvalvular atrial fibrillation - subanalysis of the J-RHYTHM registry. Circ J. 2015; 79(8): 1719–1726. 10.1253/circj.CJ-15-0095 PubMed PMID: 25971525.
   PubMed Web of Science ®Google Scholar
• Okumura K, Inoue H, Atarashi H, et al. Validation of CHA(2)DS(2)-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM registry. Circ J. 2014;787:1593–1599. PubMed PMID: 24759791.
   PubMed Web of Science ®Google Scholar
• Eckman MH, Singer DE, Rosand J, et al. Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011;4(1):14–21. 10.1161/CIRCOUTCOMES.110.958108 PubMed PMID: 21139092; PubMed Central PMCID: PMCPMC3058150.
   PubMed Web of Science ®Google Scholar